Effect of inhaled budesonide on surfactant protein expression in asthmatic mice.
D000280:Administration, Inhalation; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D019819:Budesonide / Q000008:administration & dosage*; D004195:Disease Models, Animal; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000494:pharmacology; D037662:Pulmonary Surfactant-Associated Protein A / Q000032:analysis / Q000096:biosynthesis*; D037701:Pulmonary Surfactant-Associated Protein B / Q000032:analysis / Q000096:biosynthesis*; D018125:Receptors, Transforming Growth Factor beta / Q000032:analysis / Q000096:biosynthesis; D015398:Signal Transduction / Q000187:drug effects; D051785:Smad Proteins / Q000032:analysis / Q000096:biosynthesis; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000096:biosynthesis
D001993:Bronchodilator Agents; D037662:Pulmonary Surfactant-Associated Protein A; D037701:Pulmonary Surfactant-Associated Protein B; D018125:Receptors, Transforming Growth Factor beta; D051785:Smad Proteins; D016212:Transforming Growth Factor beta; D019819:Budesonide; D010047:Ovalbumin